Literature DB >> 2565881

Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.

N C Popescu1, C R King, M H Kraus.   

Abstract

Through the use of a cDNA probe, the human erbB-2 gene was localized by in situ hybridization of normal human chromosomes at 17q11-q21. In situ hybridization of chromosomes derived from fibroblasts carrying a constitutional 15;17t(q22.3;q11.21) translocation showed that the erbB-2 gene was relocated on the rearranged chromosome 15. These results as well as grain localization on prophase chromosomes locate the erbB-2 gene at 17q12-q21.32. This localization may facilitate the search for human malignancies with chromosome changes involving the erbB-2 gene.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2565881     DOI: 10.1016/0888-7543(89)90343-1

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  48 in total

Review 1.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

2.  Accuracy and Reproducibility of HER2 Status in Breast Cancer Using Immunohistochemistry: A Quality Control Study in Tuscany Evaluating the Impact of Updated 2013 ASCO/CAP Recommendations.

Authors:  S Bianchi; S Caini; M Paglierani; C Saieva; V Vezzosi; G Baroni; A Simoni; D Palli
Journal:  Pathol Oncol Res       Date:  2014-11-04       Impact factor: 3.201

Review 3.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 4.  Mouse chromosome 11.

Authors:  A M Buchberg; M S Buckwalter; S A Camper
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

5.  Numerical aberrations of chromosomes 11 and 17 in colorectal adenocarcinomas.

Authors:  Y Tagawa; T Sawai; T Nakagoe; M Morinaga; T Yasutake; H Ayabe; M Tomita
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

6.  Correlation of the HER-2 protein expression and other clinicopathological features of ductal infiltrative breast cancer.

Authors:  Svjetlana Radović; Mirsad Babić; Mirsad Dorić; Edina Balta; Erol Kapetanović; Senad Secić
Journal:  Bosn J Basic Med Sci       Date:  2005-02       Impact factor: 3.363

Review 7.  Mouse chromosome 11.

Authors:  A M Buchberg; J J Moskow; M S Buckwalter; S A Camper
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

Review 8.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

9.  Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA).

Authors:  Maria D Corte; Juan A Rodil; Julio Vázquez; Lucia García; Juan C Rodríguez; Miguel Bongera; José C Fernández; Luis O González; Ma Luz Lamelas; Maite Allende; José L García-Muñiz; Antonio Fueyo; Francisco J Vizoso
Journal:  J Cancer Res Clin Oncol       Date:  2005-11-01       Impact factor: 4.553

10.  Anti-HER-2 engineering antibody ChA21 inhibits growth and induces apoptosis of SK-OV-3 cells.

Authors:  Anli Zhang; Hua Xue; Xiaoguang Ling; Yi Gao; Feng Yang; Liansheng Cheng; Jing Liu; Qiang Wu
Journal:  J Exp Clin Cancer Res       Date:  2010-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.